Thu, Oct 17 3:49am


NASDAQ: GLPG $10 Billion Mid-Cap. Biotech & Pharma industry. 5 Year Return 220%. 1 Year Return 54%. 2019 YTD Return 79%. Earnings in 8 days on Fri, Oct 25. (Use the Earnings tab below to add this date to your calendar.)

GLPG Profile

Market Cap 10 Billion
GLPG Description

Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.

Visit Website

GLPG Earnings

EPS -0.86 P/E Ratio 0.00
Previous Thu, Jul 25, 2019
Latest Fri, Oct 25, 2019 (In 8 days)

GLPG Dividend

Yield --
Ex-Date --
Pay Date --
History --

GLPG Charts

1 Year
Dec 27, 2018
Jul 22, 2019

Symbol Price Day Ξ” YTD Ξ”
GLPG $161.68 -0.31% 78.63%


Symbol Surfing

How can we make Symbol Surfing better?

©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy | Terms Of Service | Privacy Policy